149 related articles for article (PubMed ID: 11738485)
1. 1,2,5-Oxadiazole N-oxide derivatives as potential anti-cancer agents: synthesis and biological evaluation. Part IV.
Boiani M; Cerecetto H; González M; Risso M; Olea-Azar C; Piro OE; Castellano EE; López de Ceráin A; Ezpeleta O; Monge-Vega A
Eur J Med Chem; 2001 Oct; 36(10):771-82. PubMed ID: 11738485
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as potential hypoxic cytotoxins and DNA-binders.
Cerecetto H; González M; Risso M; Seoane G; López de Ceráin A; Ezpeleta O; Monge A; Suescun L; Mombrú A; Bruno AM
Arch Pharm (Weinheim); 2000 Nov; 333(11):387-93. PubMed ID: 11129981
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
Monge A; López de Ceráin A; Ezpeleta O; Cerecetto H; Dias E; Di Maio R; González M; Onetto S; Seoane G; Suescun L; Mariezcurrena R
Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
[TBL] [Abstract][Full Text] [Related]
4. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
[TBL] [Abstract][Full Text] [Related]
5. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part II.
Cerecetto H; González M; Onetto S; Saenz P; Ezpeleta O; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):247-58. PubMed ID: 15095418
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles.
Caneschi W; Enes KB; Carvalho de Mendonça C; de Souza Fernandes F; Miguel FB; da Silva Martins J; Le Hyaric M; Pinho RR; Duarte LM; Leal de Oliveira MA; Dos Santos HF; Paz Lopes MT; Dittz D; Silva H; Costa Couri MR
Eur J Med Chem; 2019 Mar; 165():18-30. PubMed ID: 30654237
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents.
Lakshmithendral K; Saravanan K; Elancheran R; Archana K; Manikandan N; Arjun HA; Ramanathan M; Lokanath NK; Kabilan S
Eur J Med Chem; 2019 Apr; 168():1-10. PubMed ID: 30798049
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles.
Bondock S; Adel S; Etman HA; Badria FA
Eur J Med Chem; 2012 Feb; 48():192-9. PubMed ID: 22204901
[TBL] [Abstract][Full Text] [Related]
9. A facile synthesis of novel bis-(indolyl)-1,3,4-oxadiazoles as potent cytotoxic agents.
Kumar D; Arun V; Maruthi Kumar N; Acosta G; Noel B; Shah K
ChemMedChem; 2012 Nov; 7(11):1915-20. PubMed ID: 22997171
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
11. 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships.
Cerecetto H; Di Maio R; González M; Risso M; Saenz P; Seoane G; Denicola A; Peluffo G; Quijano C; Olea-Azar C
J Med Chem; 1999 Jun; 42(11):1941-50. PubMed ID: 10354402
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives.
Du K; Cao X; Zhang P; Zheng H
Bioorg Med Chem Lett; 2014 Nov; 24(22):5318-20. PubMed ID: 25278236
[TBL] [Abstract][Full Text] [Related]
13. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, quantitative structure-activity relationship and biological evaluation of 1,3,4-oxadiazole derivatives possessing diphenylamine moiety as potential anticancer agents.
Abdel Rahman DE
Chem Pharm Bull (Tokyo); 2013; 61(2):151-9. PubMed ID: 23370194
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antitumor activity of 1,3,4-oxadiazole derivatives based on benzisoselenazolone.
Luo ZH; He SY; Chen BQ; Shi YP; Liu YM; Li CW; Wang QS
Chem Pharm Bull (Tokyo); 2012; 60(7):887-91. PubMed ID: 22790823
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Molecular Docking Study, and Cytotoxic Activity of 3,4-diaryl-5-(4-pyridinyl)-1,2,4-oxadiazole.
Zareian B; Ghadbeighi S; Amirhamzeh A; Ostad SN; Shafiee A; Amini M
Med Chem; 2016; 12(4):394-401. PubMed ID: 26558375
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
[TBL] [Abstract][Full Text] [Related]
19. 1,3,4-Oxadiazoles as Potential Pharmacophore for Cytotoxic Potentiality: A Comprehensive Review.
Sharma D; Salahuddin ; Sharma V; Kumar R; Joshi S; Kumari S; Saxena S; Mazumder A; Yar MS; Ahsan MJ
Curr Top Med Chem; 2021; 21(15):1377-1397. PubMed ID: 34126902
[TBL] [Abstract][Full Text] [Related]
20. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
